Rua Bioscience directors have warned they may have to close the NZX-listed medicinal cannabis company if sufficient capital is not obtained in its current raise.
The company has today released details of a $3.1 million pro-rata renounceable rights offer to shareholders, offering three new shares for
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
